Constitutively active luteinizing hormone receptors: Consequences of in vivo expression

Molecular and Cellular Endocrinology

Volumn 260-262, Issue , 2007, Pages 294-300

  Meehan, Thomas P ^a   Narayan, Prema ^a  

^a University of Georgia ^*  (United States)

Author keywords

Constitutive activation; Luteinizing hormone receptor; Transgenic; Yoked hormone receptor

Indexed keywords

LUTEINIZING HORMONE RECEPTOR;

FERTILITY; GENE MUTATION; GENE SEQUENCE; GENETIC ENGINEERING; HUMAN; LEYDIG CELL TUMOR; NONHUMAN; PHENOTYPE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS; STATISTICAL SIGNIFICANCE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; GENITALIA; HUMANS; MUTANT PROTEINS; PHENOTYPE; PUBERTY; RECEPTORS, LH; SIGNAL TRANSDUCTION;

EID: 33751201259     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.03.045     Document Type: Review

References (36)

1. Ahtiainen P., Rulli S.B., Shariatmadari R., Pelliniemi L.J., Toppari J., Poutanen M., and Huhtaniemi I.T. Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: a study on Hcg overexpressing transgenic mice. Oncogene 24 (2005) 7301-7309
2. Angelova K., Fanelli F., and Puett D. A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J. Biol. Chem. 277 (2002) 32202-32213
3. Ascoli M., Fanelli F., and Segaloff D.L. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 23 (2002) 141-174
4. Canto P., Soderlund D., Ramon G., Nishimura E., and Mendex J.P. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am. J. Med. Genet. 108 (2001) 148-152
5. Dierich A., Sairam M.R., Monaco L., Fimia G.M., Gansmuller A., LeMeur M., and Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13612-13617
6. Fanelli F., Themmen A.P.N., and Puett D. Lutropin receptor function: insights from natural, engineered and computer-simulated mutations. IUBMB Life 51 (2001) 149-155
7. Hearn M.T., and Gomme P.T. Molecular architecture and biorecognition process of the cysteine knot protein superfamily: part I. The glycoprotein hormones. J. Mol. Recognit. 13 (2000) 223-278
8. Hirakawa T., Galet C., and Ascoli M. MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): a novel experimental paradigm to study the functional properties of the hLHR. Endocrinology 143 (2002) 1026-1035
9. Hsu S.Y., Lai R.J., Nanuel D., and Hsueh A.J.W. Different 5′-flanking regions of the inhibin-α gene target transgenes to the gonad and adrenal in an age-dependent manner in transgenic mice. Endocrinology 136 (1995) 5577-5586
10. Huhtaniemi I. Molecular aspects of the ontogeny of the pituitary-gonadal axis. Reprod. Fertility Dev. 7 (1995) 1025-1035
11. Huhtaniemi I.T., and Themmen A.P. Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 26 (2005) 207-217
12. Kananen K., Markkula M., El-Hefnawy T., Zhang F.-P., Paukku T., Su J.-G.J., Hsueh A.J.W., and Huhtaniemi I. The mouse inhibin α-subunit promoter directs SV40 T-antigen to leydig cells in transgenic mice. Mol. Cell. Endocrinol. 119 (1996) 135-146
13. Kumar T.R., Wang Y., Lu N., and Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. 15 (1997) 201-204
14. Kumar T.R., Low M.J., and Matzuk M.M. Genetic rescue of follicle-stimulating hormone β-deficient mice. Endocrinology 139 (1998) 3289-3295
15. Latronico A.C., Lins T.S.S., Brito V.N., Arnhold I.J.P., and Mendonca B.B. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin. Endocrinol. 53 (2000) 609-613
16. Lei Z.M., Mishra S., Zou W., Xu B., Foltz M., Li X., and Rao C.V. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol. Endocrinol. 15 (2001) 184-200
17. Liu G., Duranteau L., Carel J.C., Monroe J., Doyle D.A., and Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N. Engl. J. Med. 341 (1999) 1731-1736
18. Ma X., Dong Y., Matzuk M.M., and Kumar T.R. Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 17294-17299
19. Majdic G.A.S.M., Sharpe R., Evans L., Groome N., and Saunders P. Testicular expression of inhibin and activin subunits and follistatin in the rat and human fetus and enonate and during postnatal development in the rat. Endocrinology 138 (1997) 2136-2147
20. Matzuk M.M., DeMayo F.J., Hadsell L.A., and Kumar T.R. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice. Biol. Reprod. 69 (2003) 338-346
21. Meehan T.P., Harmon B.G., Overcast M.E., Yu K.K., Camper S.A., Puett D., and Narayan P. Gonadal defects and hormonal alterations in transgenic mice expressing a single chain human chorionic gonadotropin-lutropin receptor complex. J. Mol. Endocrinol. 34 (2005) 489-503
22. Meunier H., Cajander S., Roberts V., Rivier C., Sawchenko P., Hsueh A., and Vale W. Rapid changes in the expression of inhibin a-, bA-, and bB-subunits in ovarian cell types during the rat estrous cycle. Mol. Endocrinol. 2 (1988) 1352-1363
23. Nakabayashi K., Kudo M., Hsueh A.J.W., and Maruo T. Activation of the lutenizing hormone receptor in the extracellular domain. Mol. Cell. Endocrinol. 202 (2003) 139-144
24. O'Shaughnessy P.J., and McLelland D.M.W.M. Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary. Biol. Reprod. 57 (1997) 602-608
25. Richards J.S. Hormonal control of gene expression in the ovary. Endocr. Rev. 15 (1994) 725-751
26. Richter-Unruh A., Wessels H.T., Menken U., Bergmann M., Schmittmann-Ohters K., Schaper J., Tappeser S., and Hauffa B.P. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J. Clin. Endocrinol. Metab. 87 (2002) 1052-1056
27. Risma K.A., Clay C.M., Nett T.M., Wagner T., Yun J., and Nilson J.H. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1322-1326
28. Roberts V., Meunier H., Sawchenko P., and Vale W. Differential production and regulation of inhibin subunits in rat testicular cell types. Endocrinology 125 (1989) 2350-2359
29. Rosenthal I.M., Refetoff S., Rich B., Barnes R.B., Sunthornthepvarakul T., Parma J., and Rosenfield R.L. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor-a clinical research center study. J. Clini. Endocrinol. Metab. 81 (1996) 3802-3806
30. Rulli S.B., Kuorelahti A., Karaer O., Pelliniemi L.J., Poutanen M., and Huhtaniemi I. Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143 (2002) 4084-4095
31. Rulli S.B., Ahtiainen P., Makela S., Toppari J., Poutanen M., and Huhtaniemi I. Elevated steroidogenesis, defective reproductive organs, and infertility in transgenic male mice overexpressing human chorionic gonadotropin. Endocrinology 144 (2003) 4980-4990
32. Schubert R.L., Narayan P., and Puett D. Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone. Endocrinology 144 (2003) 129-137
33. Shenker A. Activating mutations of the lutropin/choriogonadotropin receptor in precocious puberty. Receptors Channels 8 (2002) 3-18
34. Themmen A.P.N. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 130 (2005) 263-274
35. Wu C., Narayan P., and Puett D. Protein engineering of a novel constitutively active hormone-receptor complex. J. Biol. Chem. 271 (1996) 31638-31642
36. Zhang F.-P., Poutanen M., Wilbertz J., and Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol. Endocrinol. 15 (2001) 172-183